Advanced search
Publication Cover
Drug Delivery Volume 28, 2021 - Issue 1
Submit an article Journal homepage
2,476
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy

Yanwen Zhenga Department of Liver Surgery, The Second Xiangya Hospital of Central South University, Changsha, China
,
Fanhua Kongb Institute of Hepatobiliary Diseases of Wuhan University, Transplant Centre of Wuhan University, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China
,
Songyang Liuc College of Biology, State Key Laboratory of Chemo/Biosensing and Chemometrics, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Hunan University, Changsha, China
,
Xi Liud Department of Gastrointestinal Surgery, The Third Xiangya Hospital of Central South University, Changsha, China
,
Dongni Peia Department of Liver Surgery, The Second Xiangya Hospital of Central South University, Changsha, China
&
Xiongying Miaoa Department of Liver Surgery, The Second Xiangya Hospital of Central South University, Changsha, ChinaCorrespondence[email protected]
Pages 2033-2043 | Received 19 Jul 2021, Accepted 13 Sep 2021, Published online: 27 Sep 2021

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zhe Li, Jinshuai Lan, Ya Wu, Yue Ding & Tong Zhang. (2024) Homotypic cell membrane-camouflaged biomimetic PLGA nanoparticle loading triptolide for the treatment of hepatocellular carcinoma. Drug Delivery 31:1.
Read now
Nan Wang, Chi Zhang, Jiahui Wu, Dachuan Zhang, Junling Li, A. Galvbu, Leimengyuan Tang, Yan Li, Houxier Li, Shuting Tan & Xueyong Wang. (2024) Carboxymethyl chitosan and octadecylamine-coated liposome-containing WPTS: design, optimization, and evaluation. Journal of Liposome Research 34:1, pages 124-134.
Read now

Articles from other publishers (13)

Xin Jin, Wenke Jin, Linlin Tong, Jia Zhao, Lan Zhang & Na Lin. (2024) Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer. Acta Pharmaceutica Sinica B 14:7, pages 2815-2853.
Crossref
Jinhong Guo, Wenjie Yan, Hao Duan, Diandian Wang, Yaxi Zhou, Duo Feng, Yue Zheng, Shiqi Zhou, Gaigai Liu & Xia Qin. (2024) Therapeutic Effects of Natural Products on Liver Cancer and Their Potential Mechanisms. Nutrients 16:11, pages 1642.
Crossref
Shiwei Bao, Mei Yi, Bo Xiang & Pan Chen. (2024) Antitumor mechanisms and future clinical applications of the natural product triptolide. Cancer Cell International 24:1.
Crossref
Miaodong Wang, Peichun Peng, Zeshan Chen & Xin Deng. (2023) Nanoparticle Delivery of Active Traditional Chinese Medicine Ingredients: A New Strategy for the Treatment of Liver Cancer. Current Pharmaceutical Biotechnology 24:13, pages 1630-1644.
Crossref
Xiaoli Zhao, Yifan Yang, Xuerong Su, Ying Xie, Yiyao Liang, Tong Zhou, Yangqian Wu & Liuqing Di. (2023) Transferrin-Modified Triptolide Liposome Targeting Enhances Anti-Hepatocellular Carcinoma Effects. Biomedicines 11:10, pages 2869.
Crossref
Xiao Xu, Limei Xu, Caining Wen, Jiang Xia, Yuanmin Zhang & Yujie Liang. (2023) Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform. Materials Today Bio 22, pages 100760.
Crossref
Peng Chen, Pengcheng Zhao, Mingliang Hu, Lili Wang, Tong Lei, Bin Liu, Li Li, Jianyu Shi & Cheng Lu. (2023) HnRNP A2/B1 as a potential anti-tumor target for triptolide based on a simplified thermal proteome profiling method using XGBoost. Phytomedicine 117, pages 154929.
Crossref
Aalok Basu, Thanaphon Namporn & Pakatip Ruenraroengsak. (2023) Critical Review in Designing Plant-Based Anticancer Nanoparticles against Hepatocellular Carcinoma. Pharmaceutics 15:6, pages 1611.
Crossref
Chao Yuan, Yanli Liao, Shengjie Liao, Mi Huang, Duanzhuo Li, Weibin Wu, Yi Quan, Liqiang Li, Xin Yu & Wenxia Si. (2023) Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1. Frontiers in Oncology 13.
Crossref
Minhan Fu, Xuan Han, Bin Chen, Liang Guo, Lei Zhong, Po Hu, Yang Pan, Min Qiu, Peng Cao & Jing Chen. (2022) Cancer treatment: from traditional Chinese herbal medicine to the liposome delivery system. Acta Materia Medica 1:4.
Crossref
Yuyu Zhu, Zijun Ouyang, Haojie Du, Meijing Wang, Jiaojiao Wang, Haiyan Sun, Lingdong Kong, Qiang Xu, Hongyue Ma & Yang Sun. (2022) New opportunities and challenges of natural products research: When target identification meets single-cell multiomics. Acta Pharmaceutica Sinica B 12:11, pages 4011-4039.
Crossref
ZhongHua Qin, GuiPing Yu, Ran Li & Jun Zhao. (2022) Preparation of Triptolide Nano Drug Delivery System and Its Antitumor Activity In-Vitro . Journal of Biomedical Nanotechnology 18:10, pages 2417-2432.
Crossref
YunZhen Peng, GuoJing Wu, Xin Qiu, Yue Luo, YiShu Zou, XueYan Wei & Aimin Li. (2022) Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma. Frontiers in Genetics 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.